Reviewing Teladoc Health (TDOC) & Its Competitors

Teladoc Health (NYSE:TDOC) is one of 93 public companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare Teladoc Health to related businesses based on the strength of its institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends.

Risk and Volatility

Teladoc Health has a beta of 2, indicating that its stock price is 100% more volatile than the S&P 500. Comparatively, Teladoc Health’s rivals have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.

Institutional and Insider Ownership

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 42.3% of shares of all “Healthcare Technology” companies are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 16.0% of shares of all “Healthcare Technology” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Teladoc Health and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Teladoc Health	$2.53 billion	-$200.32 million	-9.99
Teladoc Health Competitors	$342.33 million	-$24.15 million	12.89

Teladoc Health has higher revenue, but lower earnings than its rivals. Teladoc Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Teladoc Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.27%	-11.63%	-5.53%
Teladoc Health Competitors	-778.92%	-33.96%	-15.64%

Analyst Ratings

This is a breakdown of current recommendations and price targets for Teladoc Health and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	2	10	5	0	2.18
Teladoc Health Competitors	447	1517	2725	88	2.51

Teladoc Health presently has a consensus price target of $8.00, indicating a potential downside of 6.92%. As a group, “Healthcare Technology” companies have a potential upside of 41.60%. Given Teladoc Health’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Teladoc Health has less favorable growth aspects than its rivals.

Summary

Teladoc Health rivals beat Teladoc Health on 7 of the 13 factors compared.

About Teladoc Health

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.